Document Detail

Ketotifen in the treatment of diabetics with various allergic conditions.
MedLine Citation:
PMID:  6115399     Owner:  NLM     Status:  MEDLINE    
A study was carried out in 30 hospitalized diabetics suffering from allergic conditions to assess the effects of ketotifen on various laboratory parameters. Ten of the patients were on diet only, 10 on biguanides plus diet, and 10 on sulphonylureas plus diet. Most were overweight. Patients received 4 mg ketotifen daily for 14 days. Oral glucose tolerance tests and other laboratory investigations were carried out before and 7 and 14 days after the start of ketotifen administration. There were no pathological changes measured in blood levels of sodium, potassium, SGPT, SGOT, alkaline phosphatase, cholesterol, triglycerides, creatinine, uric acid, non-protein nitrogen, haemoglobin, haematocrit, white cell count and differential, and platelet count. Glucose tolerance improved somewhat during the repeated oral glucose tolerance test, and there were no significant changes either in the immunoreactive insulin or growth hormone levels during the test. In the diabetics on biguanides, initial blood pressures were raised both in the lying and standing positions. The levels decreased significantly to normal during ketotifen administration. The results indicate that ketotifen can be used without problems in the treatment of diabetics with allergic disorders and its suggested that a long-term study with ketotifen in diabetic patients could be useful.
R Dolecek
Related Documents :
360749 - Insulin secretion in patients with myotonic dystrophy and their relatives.
149319 - Insulin tolerance in rats.
1464889 - Association between insulin and blood pressure in a community population with normal gl...
11850099 - Validation of simple indices to assess insulin sensitivity based on the oral glucose to...
11194559 - Influence of relative size at birth on growth and glucose homeostasis in twin lambs dur...
6328679 - The effect of the long-term ingestion of konjac-glucomannan on glucose tolerance and im...
22132939 - Diabetes in greenland and its relationship with urbanization.
11157799 - Effect of the toxic milk mutation (tx) on the function and intracellular localization o...
8397219 - Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats....
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmatherapeutica     Volume:  2     ISSN:  0308-051X     ISO Abbreviation:  Pharmatherapeutica     Publication Date:  1981  
Date Detail:
Created Date:  1981-10-25     Completed Date:  1981-10-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7606274     Medline TA:  Pharmatherapeutica     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  568-74     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biguanides / therapeutic use
Blood / drug effects
Diabetes Complications
Diabetes Mellitus / therapy*
Drug Interactions
Glucose Tolerance Test
Histamine H1 Antagonists / therapeutic use*
Hypersensitivity / complications,  drug therapy*
Middle Aged
Piperidines / therapeutic use*
Sulfonylurea Compounds / therapeutic use
Thiophenes / therapeutic use*
Reg. No./Substance:
0/Biguanides; 0/Histamine H1 Antagonists; 0/Piperidines; 0/Sulfonylurea Compounds; 0/Thiophenes; 34580-13-7/Ketotifen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Autonomic innervation of receptors and muscle fibres in cat skeletal muscle.
Next Document:  Precursor control of neurotransmitter synthesis.